Frederick Health will soon implement "the world's smallest heart pump" into its procedures, which is expected to reduce risks and patient transfers. The Impella, a temporary microaxial intravascular ...

Share on Pinterest Reports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/Shutterstock Reports of GLP-1 users developing scurvy have increased in recent months ...

ARTIFICIAL INTELLIGENCE IS PRETTY MUCH EVERYWHERE RIGHT NOW. IT’S NOT JUST CHATGPT. WE’RE VIDEOS AND MISINFORMATION. WHAT? THE TECHNOLOGY COULD SAVE YOUR LIFE. WESH 2’S MEAGHAN TAKES US TO LAKE WEIR ...

BEIJING, Feb 14 (Reuters) - China will implement zero‑tariff treatment for imports from the 53 African countries with which it has diplomatic relations, starting May 1, 2026, state media reported on ...

Vice President JD Vance announced a new push on Wednesday to create price stability in the market for critical rare earth minerals and said he wants to use a familiar Trump-world tool to accomplish it ...

Elon Musk's rocket maker SpaceX has acquired artificial intelligence startup xAI in a deal that will value the company at $1.25 trillion, CNBC has confirmed. The transaction comes ahead of a potential ...

Now that generative artificial intelligence tools have been widely implemented in retirement planning, experts suggest advisers turn to embedded AI to ramp up efficiency. Generative artificial ...

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

A sizable percentage of people using Novo (NVO) and Lilly’s (LLY) GLP-1 drugs may be able to sustain their weight loss effects even months after discontinuing the popular obesity drugs, Reuters ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

GLP-1 weight-loss drugs are more popular than ever. With their ability to increase feelings of fullness and make people eat less, they could not only reshape global food markets but the way people eat ...